Fundraising Fox
20/20 BioLabs
NASDAQ: AIDXMaryland, US · 2 known investors
Find your way into 20/20 BioLabs
Sign up to see every warm intro you have to 20/20 BioLabs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 20/20 BioLabs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
Founders & leadership
MC
Mr. CohenFounder, Chief Executive Officer, President
DL
Dr. LebowitzChief Scientific Officer
DZ
Dr. Zhou
Investors · 2
Related companies · 7
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
WefunderA platform that allows individuals to invest in private startups with minimum investments of $100, leveraging regulatory changes to democratize access to early-stage company equity.
StartEngineStartEngine is a crowdfunding platform that enables both accredited and non-accredited investors to invest in early-stage startups and collectibles through Regulation A+ and Regulation Crowdfunding offerings. The platform also provides a secondary trading marketplace for eligible securities.
KingsCrowd
trefisTrefis operates thinkHub, a data-driven investment analytics platform that uses what it calls "Understandable-AI" — an auditable, non-black-box decision system — to build and run equity portfolios (such as its High-Quality, Bayesian, and Reinforced Value strategies) aimed at outperforming the S&P 500. It serves investors and money managers, offering peer comparisons, valuation, and macro-event analyses, with practical investing carried out via an affiliated firm.
Companies working in the same space as 20/20 BioLabs.
In the news
Frequently asked questions
- What does 20/20 BioLabs do?
- 20/20 BioLabs develops AI-powered blood tests for early detection of multiple cancers and chronic diseases, using protein tumor markers and machine learning. The company offers affordable, at-home collection tests starting under $200, targeting individuals and healthcare providers seeking early disease detection.
- Who founded 20/20 BioLabs?
- 20/20 BioLabs was founded by Mr. Cohen.
- Who are 20/20 BioLabs's investors?
- 20/20 BioLabs's investors include Dellin Investments, DigitalDx Ventures.
- How much funding has 20/20 BioLabs raised?
- 20/20 BioLabs has disclosed $5M raised across 1 round.
- Where is 20/20 BioLabs headquartered?
- 20/20 BioLabs is headquartered in Maryland, US.